Clinical TrialsSearch results
Number of results: 718
Not yet recruiting
- Time needed for tracheal intubation with McGRATH MAC and AceScope
- General anesthesia
- Chaki Tomohiro
- 2023-08-28
Other
- Expanded Access Program of ONO-7702/ONO-7703 (ONO-7702/7703-03E)
- Radically unresectable BRAF V600-mutant thyroid cancer
- Hirashima Yoshinori
- 2023-08-23
Other
- NA
- IDH1 gene-mutated cholangiocarcinoma
- KANEHISA Akira
- 2023-08-23
Recruiting
- Study to Assess Adverse Events, Change in Disease Activity, and How Oral Upadacitinib Moves Through the Body of Pediatric Participants with Moderately to Severely Active Ulcerative Colitis.
- Ulcerative Colitis
- Yamazaki Hayato
- 2023-08-10
Not yet recruiting
- Investigate the benefit in modifying the treatment plan during a course of proton therapy in pancreatic and liver cancer.
- Pnacreatic cancer Liver cancer
- Uchinami Yusuke
- 2023-08-08
Recruiting
- Study to Evaluate Loncastuximab Tesirine With Rituximab Versus Immunochemotherapy in Participants With Relapsed or Refractory Diffuse Large B-Cell Lymphoma
- Patients with relapsed/refractory DLBCL
- Kondou Kazuoki
- 2023-08-04
Completed
- 33-104 : Drug Use-Results Survey of OPDIVO
- Unresectable advanced/recurrent malignant pleural mesothelioma that has progressed after cancer chem
- Kuro Toshihiko
- 2023-08-04
Recruiting
- Exploration of velocity-based resistance exercise methods for maximizing total work volume
- Healthy adult
- Tomabechi Nobuysu
- 2023-08-01
Recruiting
- A Study to Learn How Gadoquatrane Moves Into, Through, and Out of the Body and How Safe it is in Children (From Birth to <18 Years), Who Will Undergo a Contrast Enhanced MRI (Quanti Pediatric)
- pediatric participants (from birth to <18 years) undergoing contrast-enhanced MRI
- Myoishi Masafumi
- 2023-07-28
Completed
- A Study to Compare How Well Gadoquatrane Works and Its Safety With an Already Available Contrast Agent for MRI in People With Any Known or Suspected Problems of the Body (Except Brain or Spinal Cord-related Problems) (Quanti OBR)
- Adults with known or suspected pathology of any body region (except CNS)
- Myoishi Masafumi
- 2023-07-28